Technical note: estimating longer drug shelf-life with reliability plotting.

Area of Science:

• Pharmaceutical Sciences
• Analytical Chemistry
• Drug Development

Background:

• Drug stability studies are crucial for determining shelf-life.
• Extrapolation of stability data is commonly used but can be limited by statistical confidence intervals.
• Current methods may underestimate the true shelf-life of pharmaceutical products.

Purpose of the Study:

• To introduce and evaluate the application of reliability plotting for drug stability data.
• To demonstrate how reliability plotting can improve shelf-life estimations compared to standard extrapolation.
• To highlight the potential cost-saving benefits of adopting this technique.

Main Methods:

• Graphical analysis of drug stability data.
• Application of statistical confidence limits to extrapolated shelf-life estimates.
• Data transformation to achieve linearity using reliability plotting.

Main Results:

• Standard extrapolation of an 18-month stability study yielded a 19-month shelf-life.
• Reliability plotting, applied to the same data, resulted in an extended shelf-life of 23 months.
• This demonstrates a significant increase in justifiable shelf-life without additional study costs.

Conclusions:

• Reliability plotting is an underutilized yet effective method for analyzing drug stability data.
• This technique can lead to more accurate and extended shelf-life determinations.
• Pharmaceutical manufacturers can leverage reliability plotting to optimize product shelf-life and potentially reduce costs.